Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

Xiao, Ying; Zhang, Shutian; Dai, Ning; Fei, Guijun; Goh, Khean‐Lee; Jai Chun, Hoon; Sheu, Bor‐Shyang; Fung Chong, Chui; Funao, Nobuo; Zhou, Wenxia; Chen, Minhu

doi:10.1136/gutjnl-2019-318365

Public

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

Published in Gut • Aug 13, 2019

Authors:

Ying Xiao

Shutian Zhang

Ning Dai

Abstract

OBJECTIVE: To establish the non-inferior efficacy of vonoprazan versus lansoprazole in the treatment of Asian patients with erosive oesophagitis (EO). DESIGN: In this phase III, double-blind, multicentre study, patients with endoscopically confirmed EO were randomised 1:1 to receive vonoprazan 20 mg...

Subject

Lansoprazole

Medicine

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!